Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.

Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Abstract Text:

    victoria j broughton-headVictoria J Broughton-Head,james r smithJames R Smith,jagdeep shurJagdeep Shur,janis k shuteJanis K Shute,victoria j broughton-headVictoria J Broughton-Head,james r smithJames R Smith,jagdeep shurJagdeep Shur,janis k shuteJanis K Shute,

    BACKGROUND: The secretions in the cystic fibrosis (CF) airways contains high concentrations of polymers, including the respiratory mucins and varying amounts of DNA and actin, the debris of an aggressive neutrophilic inflammatory response to infection. Physical and chemical interactions between these polymers contribute to the viscoelastic nature of a material that is hard to clear without the use of mucolytics. Secretions retained in the CF airway not only restrict airflow and invite infection, but also act as a barrier to the delivery of inhaled drugs and gene therapy vectors to the underlying airway epithelium. The aim of this investigation was to develop a simple, sensitive, assay to measure the diffusion of nanospheres the size of liposomal gene therapy vectors through CF sputum, and to model the polymer interactions that limit diffusion and the diffusion-enhancing activity of mucolytics. METHODS: The diffusion of 200 nm fluorescent carboxylated nanospheres through CF sputum was investigated using a diffusion assay based on the micro-Boyden chamber. Atomic force microscopy (AFM) was used to visualise and measure the pore diameter in CF sputum. The effect of the mucolytics deoxyribonuclease (DNase), N-acetylcysteine and gelsolin on the diffusion of nanospheres though synthetic biogels comprising mixtures of DNA, mucin and F-actin was also investigated. RESULTS: CF sputum significantly retarded the diffusion of 200 nm nanospheres. Pore diameter in CF sputum was highly variable, with a mean greater than 200 nm. At concentrations found in the CF airway, DNA (1-10 mg/ml) and mucin (25-50 mg/ml) also significantly reduced the diffusion of nanospheres. The barrier effects of DNA and mucin were not additive, and the additional presence of F-actin (5 mg/ml) did not influence diffusion of the nanospheres. However, actin (5mg/ml) completely inhibited the ability of DNase (2.9 microg/ml) and N-acetylcysteine (5 mM) to enhance diffusion. The activity of the mucolytics, DNase and N-acetylcysteine, was not restored by the addition of the actin depolymerising agent gelsolin (250nM). CONCLUSION: Actin does not contribute to the barrier properties of CF sputum, but is a key determinant of the ability of mucolytics to enhance drug diffusion through synthetic and biological mucus.

    Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Publishing Authors By Initials

    vj broughton-headVJ Broughton-Head,jr smithJR Smith,j shurJ Shur,jk shuteJK Shute,vj broughton-headVJ Broughton-Head,jr smithJR Smith,j shurJ Shur,jk shuteJK Shute,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Pulmonary pharmacology & therapeutics

    VOLUME: 20

    Page Numbers: 708-17

    Journal Abbreviation:

    ISSN: 1094-5539

    DAY: 9

    MONTH: 09

    YEAR: 2006

    Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9715279

    Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.

    AFFILIATION: School of Pharmacy and Biomedical Sciences, Institute of Biomedical and Biomolecular Sciences, University of Portsmouth, St Michael's Building, White Swan Road, Portsmouth, PO1 2DT, UK.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pulm Pharmacol Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News